David Meyronet
Affiliations: | Universite Lyon 1, Villeurbanne, Auvergne-Rhône-Alpes, France |
Area:
Semaphorin, CRMP, MAPK, Cancer, Marker, Cell migration, ApoptosisGoogle:
"David Meyronet"Parents
Sign in to add mentor| Nicole Thomasset | grad student | 2009 | Universite Lyon 1 (Neurotree) | |
| (Implication des collapsin response mediator protein (crmp) et des voies de signalisation des semaphorines en pathologie tumorale) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| D'Angelo F, Ceccarelli M, Tala, et al. (2018) The molecular landscape of glioma in patients with Neurofibromatosis 1. Nature Medicine |
| Royet A, Broutier L, Coissieux MM, et al. (2017) Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4. Oncotarget. 8: 23750-23759 |
| Denicolaï E, Tabouret E, Colin C, et al. (2016) Molecular heterogeneity of glioblastomas: does location matter? Oncotarget. 7: 902-13 |
| Frappaz D, Chinot OL, Meyronet D, et al. (2016) MEVITEM: A European, randomized, open-label Phase I/II of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent/ refractory medulloblastoma presenting an activation of the Sonic Hedgehog pathway. Journal of Clinical Oncology. 34 |
| Moutal A, Honnorat J, Massoma P, et al. (2015) CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Research. 75: 3519-28 |
| Meyronet D, Dorey A, Massoma P, et al. (2015) The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 975-91 |
| Rivera LB, Meyronet D, Hervieu V, et al. (2015) Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Reports. 11: 577-91 |
| Brot S, Malleval C, Benetollo C, et al. (2013) Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation. Experimental Cell Research. 319: 588-99 |
| Meyronet D, Massoma P, Thivolet F, et al. (2008) Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. The American Journal of Surgical Pathology. 32: 1699-708 |
| Kusy S, Nasarre P, Chan D, et al. (2005) Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia (New York, N.Y.). 7: 457-65 |